Atteya 2004.

Methods	Randomisation details were not reported Blinded outcome assessor No information about withdrawals Single centre, outpatients
Participants	Saudi Arabia Recruited via the King Saud Univerity 6 participants: 2 intervention, 2 control, 2 no treatment Inclusion criteria: cerebrovascular accident between 1 and 6 months; 10° of active extension to the metacarpophalangeal and interphalangeal joints and 20° at wrist Exclusion criteria: significant cognitive impairment, haemorraghic lesion, significant spasticity, significant pain of the upper limb Mean age (SD): intervention group: 55 (2.8) years, control group: 52 (4.2) years, no treatment group: 56 (15.5) years % women: intervention group 50%, control group: 50%, no treatment group: 50% Stroke details: only ischaemic, 50% with right hemiparesis in each group Time since stroke, mean (SD): intervention group 5.6 (0.3) months, control group 3.95 (2.3) months, no intervention group 4.65 (1.2) months
Interventions	mCIMT versus control versus no treatment CIMT: physical and occupational therapy focused on PNF with emphasis on ADL tasks, compensatory techniques with the unaffected side, 2 functional tasks of the WMFT with shaping techniques Amount of restraint: 5 waking hours per day Anatomical region restraint: arm and hand Control: physical and occupational therapy focused on PNF with emphasis on ADL tasks, compensatory techniques with the unaffected side Session duration: 1 hour per day, 3 days per week, 10 weeks for each treatment group
Outcomes	Measures pre/post treatment Arm motor function: ARAT, WMFT2 Perceived arm motor function: MAL Arm motor impairment: FMA
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Quote: "all subjects were randomly assigned ... with an equal probability" Comment: insufficient information to make a judgment
Allocation concealment (selection bias)	Unclear risk	No information provided
Blinding (performance bias and detection bias) All outcomes	Low risk	Blinding of outcome assessor
Incomplete outcome data addressed? (Post‐treatment)	Unclear risk	The study provided no information about withdrawals